These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
Charles River Laboratories International, Inc. CRL | 186.52 186.52 | +2.42% 0.00% Pre |
Infinera Corporation INFN | 6.74 6.74 | -0.44% 0.00% Pre |
NIKE, Inc. Class B NKE | 78.91 79.16 | +0.08% +0.32% Pre |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- JP Morgan analyst Matthew Boss downgraded NIKE, Inc. (NYSE:NKE) from Overweight to Neutral, while cutting the price target from $116 to $83. Nike shares gained 0.1% to close at $94.19 on Thursday. See how other analysts view this stock.
- Argus Research analyst David Toung downgraded the rating for Charles River Laboratories International, Inc. (NYSE:CRL) from Buy to Hold. Charles River shares gained 0.3% to close at $207.35 on Thursday. See how other analysts view this stock.
- Stifel analyst Jim Duffy downgraded the rating for NIKE, Inc. (NYSE:NKE) from Buy to Hold and slashed the price target from $117 to $88. Nike shares gained 0.1% to close at $94.19 on Thursday. See how other analysts view this stock.
- Needham analyst Ryan Koontz downgraded Infinera Corporation (NASDAQ:INFN) from Buy to Hold. Infinera shares rose 1.5% to settle at $5.26 on Thursday. See how other analysts view this stock. See how other analysts view this stock.
- Morgan Stanley analyst Alex Straton downgraded NIKE, Inc. (NYSE:NKE) from Overweight to Equal-Weight, while lowering the price target from $114 to $79. Nike shares gained 0.1% to close at $94.19 on Thursday. See how other analysts view this stock.
Check This Out: Top 3 Real Estate Stocks You’ll Regret Missing In June